Total : 4
| No. | Title | Attached | Date | View |
|---|---|---|---|---|
| 4 | Samyang Holdings Biopharmaceuticals Division’s PCL Filler “Lafullen” Proven for Safety and Efficacy | 2022. 05. 13 | 260 | |
| 3 | Samyang Holdings Biopharmaceuticals Division Acquires Approval for Cosmetic Dermal Filler ‘Lafullen’ | 2021. 12. 03 | 255 | |
| 2 | Samyang Holdings Files for Marketing Authorization for Cosmetic Surgery Filler “Lafullen” | 2021. 12. 03 | 132 | |
| 1 | Information about PR Tab | 2020. 03. 05 | 182 |
295, Pangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, Korea TEL +82-2-2157-9111 FAX +82-2-2157-9063
Privacy Policy [View Update] COPYRIGHTⓒ2025 SAMYANG BIOPHARM. ALL RIGHTS RESERVED.
Privacy Policy [View Update] COPYRIGHTⓒ2025 SAMYANG BIOPHARM. ALL RIGHTS RESERVED.